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Abstract
Purpose The association between dietary saturated fatty acids (SFA) intake and type 2 diabetes (T2D) remains unclear. 
This study aimed at investigating the association between SFA intake and T2D risk based on (1) individual SFA (differing 
in carbon chain length), (2) food sources of SFA and (3) the substituting macronutrients.
Methods 37,421 participants from the European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-
NL) cohort were included in this study. Baseline dietary intake was assessed by a validated food frequency questionnaire. 
T2D risks were estimated by Cox regression models adjusted for non-dietary and dietary covariates.
Results 893 incident T2D cases were documented during 10.1-year follow-up. We observed no association between total SFA 
and T2D risk. Marginally inverse associations were found for lauric acid (HR per 1 SD of energy%, 95% CI 0.92, 0.85–0.99), 
myristic acid (0.89, 0.79–0.99), margaric acid (0.84, 0.73–0.97), odd-chain SFA (pentadecylic plus margaric acids; 0.88, 
0.79–0.99), and cheese derived SFA (0.90, 0.83–0.98). Soft and liquid fats derived SFA was found related to higher T2D risk 
(1.08, 1.01–1.17). When substituting SFA by proteins, carbohydrates and polyunsaturated fatty acids, significantly higher 
risks of T2D were observed (HRs per 1 energy% ranging from 1.05 to 1.15).
Conclusion In this Dutch population, total SFA does not relate to T2D risk. Rather, the association may depend on the types 
and food sources of SFA. Cheese-derived SFA and individual SFA that are commonly found in cheese, were significantly 
related to lower T2D risks. We cannot exclude the higher T2D risks found for soft and liquid fats derived SFA and for substi-
tuting SFA with other macronutrients are influenced by residual confounding by trans fatty acids or limited intake variation 
in polyunsaturated fatty acids and vegetable protein.
Keywords Saturated fatty acids · Type 2 diabetes · Nutrition · Epidemiology · Cohort study
Background
Dietary guidelines recommend that intake of total satu-
rated fatty acids (SFA) should not exceed 10% of energy 
per day [1, 2]. Dietary SFA were considered to be related 
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with increased risk of type 2 diabetes (T2D) due to previous 
evidence from prospective studies that found SFA associated 
with impaired insulin sensitivity or glucose tolerance [3–5]. 
However, a recent meta-analysis, which included eight pro-
spective studies, found no association between SFA and 
incident T2D, with a relative risk (RR) of 0.95 (95% CI 
0.88, 1.03) between extreme intake levels [6]. Evidence is 
accumulating that the association between SFA and T2D 
might depend on carbon chain length, food sources and/or 
the substituting macronutrients, which have not been thor-
oughly studied yet [7, 8].
First, individual SFA that differ in carbon chain length 
may have different associations with T2D risk. So far, 
only three studies have addressed the associations between 
intakes of individual SFA through self-reported dietary 
measurements and T2D [7, 9, 10]. These studies investigated 
a selection of individual SFA, and showed dissimilarities in 
the associations of individual SFA with T2D risk. Except 
for palmitic acid, the selection of SFA differed between the 
studies, which hampers the comparison between the studies.
Second, the association between SFA and T2D risk can be 
modulated by its food sources. As far as we know, no study 
has investigated SFA derived from different food sources in 
relation to T2D risk. However, a recent cross-sectional study 
found that SFA from meat was positively associated with 
more insulin resistance and less insulin secretion, whereas 
SFA from dairy and plant sources were beneficially related 
to these markers [11]. In addition, the main food sources of 
SFA, meat and dairy products were found to be differently 
associated with T2D risk. A systematic review and meta-
analysis of 17 cohort studies found that meat intake was 
related to an increased risk of T2D [12], whereas a recent 
meta-analysis of 22 cohort studies found dairy products 
intake to be inversely related to T2D risk [13]. These find-
ings stress the importance of clarifying the food source of 
SFA with regard to T2D risk.
Third, the association may also depend on macronutrients 
that substitute SFA in the diet. The Nurses’ Health Study 
and Iowa’s Women Study found that replacing energy from 
SFA with polyunsaturated fatty acids (PUFA) was related 
to lower T2D risk [14, 15]. However, no other prospective 
study has looked into the association between substituting 
SFA with macronutrients other than PUFA, and incident 
T2D.
The aim of this study was to investigate the associations 
between intake of SFA and risk of incident T2D in a Dutch 
population based on (1) individual SFA (differing in carbon 
chain length), (2) the food sources of SFA and (3) the macro-
nutrients that substitute SFA.
Methods
Study population
The European Prospective Investigation into Cancer and 
Nutrition-Netherlands (EPIC-NL) cohort consists of 
the MORGEN (Monitoring Project on Risk Factors for 
Chronic Diseases) and the Prospect cohorts. The design 
and rationale of EPIC-NL were described in detail else-
where [16]. Briefly, both cohorts were set up between 1993 
and 1997 and baseline measurements were performed in 
40,011 participants. The MORGEN cohort consisted of 
22,654 men and women aged 20 to 59 years from three 
Dutch towns (Amsterdam, Doetinchem and Maastricht) as 
a random sample of the general population. The Prospect 
cohort included 17,357 women aged from 49 to 70 years, 
who participated in the Dutch breast cancer-screening 
program. Both studies complied with the Declaration of 
Helsinki. All participants signed informed consent before 
inclusion. The MORGEN was approved by the medical 
ethics committee of the Netherlands Organization for 
Applied Scientific Research (TNO), and the Prospect was 
approved by the institutional review board of the Univer-
sity Medical Centre Utrecht.
For this study, participants were excluded when one 
of the following criteria was fulfilled: participants who 
withheld permission for linkage with disease registries 
(n = 1046); prevalent diabetes cases at baseline (n = 679); 
participants with missing information of dietary intake 
(n = 180) and other co-variables, such as education infor-
mation and physical activity level, (n = 339); participants 
with implausible energy intake based on the ratio of 
reported energy intake to estimated basal metabolic rate, 
i.e., the top or bottom 0.5% of the ratio (n = 346); leaving 
a total of 37,421 men and women for analyses.
Measurement of food intake, saturated fatty acids 
and other nutrients
Food intake was assessed by a self-administered Food 
Frequency Questionnaire (FFQ) on the usual consump-
tion frequency of 79 main food categories during the year 
preceding enrolment. The FFQ was described in detail 
elsewhere [17]. The FFQ was validated against 12 24-h 
recalls between both genders before the start of the study 
[18]. Spearman’s correlation coefficients for intake of total 
SFA and individual SFA ranged from 0.53 to 0.71 in men 
and from 0.30 to 0.66 in women [19].
The intakes for all micronutrients and macronutrients 
except individual SFA were calculated based on the Dutch 
food composition table 1996 [20]. The intake of individual 
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SFA was calculated from the Dutch food composition 
table 1998 (digital update). Using the analogy of a pre-
vious research [19], seven independent predefined food 
groups were identified which together contribute > 82% of 
the mean total SFA intake in the study population: butter, 
cheese, milk and milk products, meat, cakes, snacks and 
fats. The group of fats was separated into two subgroups 
based on their SFA content: hard and solid fats (including 
margarines and fats in wrappers and solid frying fats, all of 
which contained ≥ 20 g SFA/100 g of the product) and soft 
and liquid fats (including soft margarines, vegetable oils, 
liquid fats, and frying oils, all of which contained < 20 g 
SFA/100 g of the product). The remaining food groups 
were aggregated and labelled as the others.
Intake of total SFA was calculated as the sum of SFA 
derived from the predefined food groups mentioned above. 
Considering relative low intakes of single individual SFA, 
two additional groups were made to add efficiency of the 
study: short- and medium-chain SFA (sum of butyric, cap-
roic, caprylic and capric acids) and odd-chain SFA (penta-
decylic plus margaric acids).
Energy reporting status of participants was estimated by 
comparison between self-reported energy intake and BMR 
(Basal metabolic rate, which was calculated using the Schof-
ield equation [21]). According to the Goldberg cut-offs [22], 
participants with an energy intake vs. BMR of < 1.14 were 
defined as energy under-reporters, whereas those with an 
energy intake vs. BMR of > 2.40 were classified as energy 
over-reporters. Both under-reporters and over-reporters were 
defined as mis-reporters, while remaining participants were 
defined as normal energy-reporters.
Alcohol consumption was categorized as follows: 0, 
0.1–6.0, 6.1–12.0, 12.1–24.0, and > 24.0 g/day for women 
and 0, 0.1–6.0, 6.1–12.0, 12.1–24.0, 24.1–60.0, and > 60.0 g/
day for men. Glycaemic index (GI) of foods, a measure of 
the extent to which foods raise the blood glucose level, was 
obtained from international table complied by Foster-Powell 
et al. [23]. To adjust for total energy intake, intake of total 
SFA, individual SFA, SFA from specific food groups, or 
other macronutrient intake was calculated and expressed as 
nutrient density, and micronutrients were adjusted through 
use of the residual method [24].
Ascertainment and verification of diabetes
Three sources of ascertaining incidence T2D were included 
in this study: self-report, hospital discharge diagnoses and 
urinary glucose strip tests (only among the Prospect partici-
pants, 1.6% of total potential diabetes cases). Verification of 
potential diabetes cases detected by any of these methods 
was carried out with information from participants’ general 
practitioner or pharmacist. Verification information was 
available for 89% of the potential diabetes cases, and 72% 
of these cases were verified as T2D and subsequently used 
for the analysis. The process of ascertainment and verifica-
tion of incident and prevalent diabetes cases is described in 
detail elsewhere [25].
Other measurements
At baseline, information on demographic characteristics, 
lifestyle characteristics, the presence of chronic diseases, and 
risk factors of chronic diseases was obtained with general 
questionnaires. Smoking status was categorized as current, 
past or never smoked. Family history of diabetes was defined 
as at least one parent with diabetes. Education was classified 
as low, middle and high education. Physical activity was 
measured with a validated questionnaire, from which the 
Cambridge Physical Activity Index was calculated and cat-
egorized as inactive, moderately inactive, moderately active 
and active [26].
A baseline physical examination was performed accord-
ing to standard operating procedures. Body weight, height, 
waist circumference and blood pressure were measured. 
BMI was calculated as weight divided by height squared (kg/
m2). Systolic and diastolic blood pressures were obtained as 
the mean of two measurements in the supine position on the 
left arm using a random zero sphygmomanometer (MOR-
GEN), or on the right arm using a BOSO Oscillomat (Bosch 
& Son, Jungingen, Germany) (Prospect). Hypertension was 
defined when one or more of the following criteria were 
fulfilled: diastolic blood pressure > 90 mmHg, systolic blood 
pressure > 140 mmHg, self-reported presence of hyperten-
sion or use of hypertensive medication. Hyperlipidaemia 
was defined through self-reported diagnosis and/or use of 
medication.
Data analysis
Baseline characteristics of the study population were cal-
culated across quartiles of total SFA intake in percentage 
of energy and presented as means (standard deviation) and 
median (interquartile range) for continuous variables, or per-
centage for categorical variables. Correlations between die-
tary intakes of total SFA, individual SFA and SFA from dif-
ferent food sources, as well as correlations between intakes 
of SFA from different food sources, total fatty acids from 
that food source and the food source itself, were calculated 
using Pearson correlations coefficients.
Person-years were calculated as the time between the 
date of the study entry and the dates of diabetes diagno-
sis, death, loss to follow-up or end of follow-up (1 January 
2006), whichever came first. The endpoint of analysis was 
incident T2D.
Cox proportional hazard regression models were used 
to calculate HRs with 95% CIs for the association between 
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SFA intake and risk of T2D. Total SFA intake was evaluated 
per 1% of energy and entered as a continuous variable into 
Cox regression models. In addition to a crude model which 
was adjusted for total energy intake (Model 1), four models 
were constructed to adjust for potential confounding. Model 
2 was adjusted for sex (men or women) and age at baseline 
(continuous). Model 3 was additionally adjusted for lifestyle 
and demographic factors: alcohol consumption level (six cat-
egories), smoking (three categories), physical activity (four 
categories), and education level (three categories). Model 4 
was additionally adjusted for dietary factors (continuous): 
energy-adjusted intake of trans fatty acids, protein (both 
animal- and vegetable-), dietary cholesterol, vitamin E and 
fibre. Model 5 was additionally adjusted for BMI (continu-
ous) and waist circumference (continuous). Similar mod-
els were used for intake of SFA in grams per day. Intakes 
of individual SFA or SFA from specific food sources were 
separately evaluated per 1 SD of intake and entered into Cox 
models as continuous variables. We used the same adjust-
ment models as described above, except that we additionally 
adjusted for the sum of all other consumed SFA.
Cox models were converted into substitution models to 
estimate the risk of T2D when energy intake from total SFA 
was substituted with an equal amount of energy from each 
of the other macronutrients (PUFA, monounsaturated fatty 
acids (MUFA), trans fatty acids, total carbohydrates, animal 
protein, and vegetable protein) [27]. We choose to model the 
substitutions per 1 en% as this best matched with the level 
and variation of intake of the macronutrients. Total energy 
intake from all macronutrients except energy from alcohol 
consumption was also included. By excluding SFA intake 
from the models, the HR for each macronutrient can be 
interpreted as the difference in T2D risk for each additional 
intake of 1% of energy from that particular macronutrient 
at the expense of 1% of energy from SFA. Additionally, 
the analysis for substitution with total carbohydrates was 
stratified for tertiles of the GI distribution, to differentiate 
in carbohydrate quality. In this way, the substitution of SFA 
with carbohydrates in GI tertiles 1, 2, and 3 represented the 
substitution of SFA with carbohydrates in participants with 
a low-, medium-, and high-GI diet, respectively.
The proportional hazards assumption was tested by calcu-
lating Schoenfeld residuals and visual inspection of log–log 
plots, no deviation was detected. Interactions of total SFA 
intake (en%) with BMI categories (< 25.0, 25.0–29.9 and 
≥ 30.0 kg/m2), family history of T2D (without family his-
tory and with family history), energy reporting status (mis-
reporters and normal energy-reporters) and sex (men and 
women) were estimated using a likelihood ratio test and by 
including continuous interaction terms in the multivariable 
adjusted model (model 5). The analysis was repeated in the 
same population after excluding the first 2 years of follow-up 
to minimize the possibility of reverse causation. The analysis 
was also performed in the population after excluding preva-
lent cases of cancer or cardiovascular disease or hyperten-
sion or hyperlipidaemia and participants who had a stroke or 
myocardial infarction, due to their possible dietary changes 
caused by the illness. Furthermore, in additional analyses, 
we estimated the associations between non-SFA fatty acids 
derived from different food sources (per 1 SD of intake) and 
T2D risk, to see whether we can actually tease SFA apart 
from other fatty acids derived from the same food source in 
relation with T2D.
All statistical analyses were executed in SAS 9.4 (SAS 




In this study population (mean age 49 years, 74.4% women), 
participants with a relatively high SFA intake were on aver-
age older women with a lower education level and were more 
likely to be a smoker and less devoted to physical activity. 
They also tended to have a higher BMI and waist circumfer-
ence, a higher blood pressure, but were less likely to have 
hyperlipidaemia (Table 1). Furthermore, participants with 
high SFA intake reported higher intakes of MUFA, trans 
fatty acids, animal protein, cholesterol, vitamin E, vitamin D 
and calcium, and lower intakes of vegetable protein, carbo-
hydrates, fibre and alcohol. Dietary GI and intake of PUFA 
were similar across SFA intake levels.
The mean ± SD baseline intake of total SFA in the study 
population was 14.0 ± 2.6 percentage of energy. More than 
95% of the population surpassed the upper intake limit of 
10% of energy per day recommended by the Health Coun-
cil of the Netherlands. The long-chain SFA palmitic acid 
(51.1%) and stearic acid (25.2%) represented most of the 
SFA intake (Supplemental Fig. 1). Cheese (17.0%), meat 
(16.9%), milk and milk products (15.8%) were the main food 
sources of SFA (Supplemental Fig. 2). High Pearson’s cor-
relations were observed between palmitic and stearic acids 
(r = 0.92), myristic and pentadecylic acids (r = 0.92), myris-
tic and margaric acids (r = 0.85), pentadecylic and margaric 
acids (r = 0.88) (Supplemental Table 1). SFA from specific 
food source was highly correlated with total fatty acids from 
that food source, as well as the intake of the food source 
itself (Supplemental Tables 2 and 3).
Total SFA intake and T2D risk
During a median follow-up of 10.1 years, 893 inci-
dent T2D cases were documented. After multivari-
able adjustment for lifestyle and demographic factors, 
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Table 1  Baseline characteristics across quartiles of saturated fatty acid intake (en%) in 37,421 participants from the EPIC-NL cohort
en% percentage of energy, EPIC-NL European Prospective Investigation into Cancer and Nutrition-Netherlands, Q quartiles
a Low: primary education up to completing intermediate vocational education; middle: up to higher secondary education; high: those with higher 
vocational education and university
b Categorized according to Cambridge Physical Activity Index (CPAI)
c High: women who consume > 24 g/day and men who consume > 60 g/day
d Mis-reporters of energy intake: subjects with an energy intake vs. BMR < 1.14 or > 2.40
e Defined by a physician-diagnosed self-report, measured hypertension (> 140 systolic or > 90 diastolic) or use of hypertensive medication
Median (intake range), en% Q1: 10.9(2.1–12.3) Q2: 13.2(12.3–13.9) Q3:14.7(13.9–15.6) Q4:17.3(15.6–27.1)
Subject, n 9355 9355 9356 9355
Incident T2D cases, n 198 218 223 254
Age, year 48 ± 13 48 ± 12 49 ± 12 52 ± 11
Male, % 28.6 29.3 24.8 19.7
High educational  levela, % 24.3 22.5 19.9 16.1
High physical  activityb, % 42.4 43.3 41.9 39.6
Current smoker, % 29.2 29.4 30.1 33.5
High alcohol  consumerc, % 23.6 15.9 11.5 8.4
Family history of T2D, % 17.0 17.1 18.7 19.3
Mis-reporters of energy  intaked, % 34.4 24.9 21.6 21.0
BMI, kg/m2 25.3 ± 3.8 25.5 ± 3.8 25.7 ± 4.0 26.0 ± 4.2
Waist circumference, cm 84.3 ± 11.1 84.9 ± 11.3 85.2 ± 11.3 85.9 ± 11.8
Hypertensione, % 37.4 35.3 36.0 38.5
Hyperlipidaemia, % 12.3 8.3 6.8 5.5
Energy intake, kcal 1923.3 ± 593.5 2075.2 ± 607.9 2099.9 ± 597.7 2112.5 ± 611.8
Saturated fatty acid intake, g/day 23.4 ± 8.0 30.4 ± 9.0 34.4 ± 9.9 40.6 ± 12.3
Saturated fatty acid intake, en% 10.9 ± 1.2 13.2 ± 0.5 14.7 ± 0.5 17.3 ± 1.5
Lauric acid (12:0), en% 0.5 ± 0.2 0.6 ± 0.2 0.7 ± 0.2 0.8 ± 0.3
Myristic acid (14:0), en% 1.1 ± 0.3 1.4 ± 0.3 1.6 ± 0.3 2.0 ± 0.4
Pentadecylic acid (15:0), en% 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.1 0.3 ± 0.1
Palmitic acid (16:0), en% 5.8 ± 0.8 6.7 ± 0.6 7.4 ± 0.6 8.5 ± 0.9
Margaric acid (17:0), en% 0.1 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
Stearic acid (18:0), en% 2.8 ± 0.5 3.3 ± 0.4 3.7 ± 0.4 4.2 ± 0.5
Sum of butyric (4:0) through capric (10:0) acid, en% 0.5 ± 0.2 0.6 ± 0.2 0.7 ± 0.2 0.9 ± 0.3
Sum of pentadecylic (15:0) and margaric (17:0) acid, en% 0.3 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.5 ± 0.1
SFA from food source, g/day
Butter 0.8(0.4–1.5) 1.3(0.7–2.2) 1.6(0.9–3.0) 2.5(1.3–6.4)
Cheese 3.1(1.5–4.8) 4.2(2.6–6.7) 5.4(3.3–7.9) 6.9(3.9–10.5)
Milk and milk products 3.4(1.9–5.3) 4.6(2.8–6.7) 5.1(3.2–7.5) 5.6(3.4–8.3)
Meat 3.8(2.1–5.8) 5.0(3.1–7.2) 5.7(3.5–7.8) 6.1(3.8–8.7)
Cakes and cookies 1.1(0.5–2.1) 1.6(0.8–2.8) 1.9(1.0–3.2) 2.0(1.0–3.3)
Snacks 0.5(0.2–1.2) 0.7(0.3–1.4) 0.7(0.3–1.4) 0.6(0.2–1.1)
Hard, solid fat 1.0(0.3–2.1) 1.8(0.8–3.3) 2.5(1.1–4.5) 3.7(1.7–6.5)
Soft, liquid fat 1.8(1.0–2.9) 2.0(1.2–3.2) 1.9(1.1–3.1) 1.5(0.7–2.6)
Others 4.8(3.3–6.8) 5.3(3.8–7.7) 5.4(3.8–7.7) 5.0(3.5–7.3)
PUFA, en% 6.3 ± 1.8 6.5 ± 1.7 6.5 ± 1.6 6.3 ± 1.6
MUFA, en% 8.2 ± 1.8 9.3 ± 1.6 10.0 ± 1.6 11.0 ± 1.8
trans Fat, en% 1.1 ± 0.4 1.3 ± 0.4 1.5 ± 0.4 1.7 ± 0.5
Animal protein, en% 9.2 ± 2.8 9.7 ± 2.5 10.0 ± 2.3 10.6 ± 2.4
Vegetable protein, en% 6.0 ± 1.2 5.7 ± 0.9 5.5 ± 0.9 5.1 ± 0.8
Carbohydrates, en% 49.2 ± 6.8 46.4 ± 5.3 44.4 ± 4.9 41.1 ± 5.0
Fibre, g/day 24.8 ± 5.6 23.7 ± 4.6 23.0 ± 4.3 21.8 ± 4.2
Cholesterol, g/day 12.4 ± 3.5 12.4 ± 3.2 12.3 ± 3.1 11.8 ± 3.1
Vitamin E, mg/day 185.2 ± 54.8 208.8 ± 51.8 224.1 ± 51.6 250.6 ± 57.6
Vitamin D, mg/day 2.4 ± 0.9 2.7 ± 0.8 3.0 ± 0.8 3.2 ± 0.9
Calcium, mg/day 1004.3 ± 370.7 1040.2 ± 341.2 1078.0 ± 336.5 1139.1 ± 352.8
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dietary factors, BMI and waist circumference (model 
5), no significant association between intake of energy 
from total SFA with risk of T2D was observed  (SFAtotal 
HR per 1% of energy: 0.97; 95% CI 0.94, 1.00). This result 
was similar when intake of SFA was modelled in grams 
per day  (SFAtotal HR per 1 g/d: 1.00; 95% CI 0.98, 1.01) 
(Table 2).
Intake of individual SFA and risk of T2D
Table 3 shows the HRs for the association between indi-
vidual SFA differing in carbon chain length and risk of 
T2D. After multivariable adjustment (model 5), significantly 
lower T2D risks were observed for each additional SD of 
intake of energy from lauric acid  (HRper SD increase: 0.92; 95% 
CI 0.85, 0.99), myristic acid  (HRper SD increase: 0.89; 95% CI 
0.79, 0.99), margaric acid  (HRper SD increase: 0.84; 95% CI 
Table 2  Multivariable HRs with 95% CIs for the association between the intake of total SFA and incidence of type 2 diabetes in 37,421 partici-
pants from the EPIC-NL cohort
Obtained from Cox proportional hazards regression models. EPIC-NL, European Prospective Investigation into Cancer and Nutrition-Nether-
lands
a en%, percentage of energy. Total SFA intake was evaluated as en% and entered as a continuous variable
b Total SFA intake was evaluated as g/day and entered as a continuous variable
c Crude model; adjustment for total energy intake
d Adjustments for sex, age
e Additional adjustments for education level, energy-adjusted alcohol consumption level, smoking status, physical activity level
f Additional adjustments for energy-adjusted intake of animal protein, vegetable protein, trans fatty acids, vitamin E, dietary fibre and cholesterol
g Additional adjustments for BMI and waist circumference
Median intake Model  1c Model  2d Model  3e Model  4f Model  5g
Total SFA per 1 en%a 14 en%/day 1.05 (1.03, 1.08) 1.02 (1.00, 1.05) 1.00 (0.97, 1.03) 0.96 (0.93, 0.99) 0.97 (0.94, 1.00)
Total SFA per  gb 32 g/day 1.03 (1.02, 1.04) 1.02 (1.00, 1.03) 1.00 (0.99, 1.02) 0.99 (0.98, 1.01) 1.00 (0.98, 1.01)
Table 3  Multivariable HRs with 95% CIs for the associations between the intakes of individual SFA (en %) and incidence of type 2 diabetes in 
37,421 participants from the EPIC-NL cohort
Obtained from Cox proportional hazards regression models. EPIC-NL, European Prospective Investigation into Cancer and Nutrition-Nether-
lands
a HRs are expressed per SD en%
b Crude model; adjusted for total energy intake
c Adjusted for sex, age and sum of other SFA
d Additional adjustments for education level, energy-adjusted alcohol consumption level, smoking status, physical activity level
e Additional adjustments for energy-adjusted intake of animal protein, vegetable protein, trans fatty acids, vitamin E, dietary fibre and cholesterol




SDa Model  1b Model  2c Model  3d Model  4e Model  5f
Lauric acid (12:0) 0.63 0.24 1.03 (0.97, 1.10) 0.88 (0.82, 0.94) 0.89 (0.83, 0.95) 0.89 (0.83, 0.97) 0.92 (0.85, 0.99)
Myristic acid (14:0) 1.51 0.45 1.04 (0.97, 1.10) 0.89 (0.83, 0.96) 0.91 (0.85, 0.97) 0.78 (0.70, 0.87) 0.89 (0.79, 0.99)
Pentadecylic (15:0) 0.21 0.08 1.01 (0.94, 1.08) 0.89 (0.82, 0.95) 0.92 (0.86, 0.99) 0.79 (0.71, 0.88) 0.90 (0.80, 1.00)
Palmitic acid (16:0) 7.06 1.22 1.08 (1.02, 1.16) 1.05 (0.99, 1.12) 1.05 (0.98, 1.11) 0.95 (0.84, 1.08) 0.90 (0.80, 1.03)
Margaric acid (17:0) 0.16 0.04 1.09 (1.02, 1.17) 1.00 (0.93, 1.07) 1.02 (0.95, 1.09) 0.76 (0.66, 0.87) 0.84 (0.73, 0.97)
Stearic acid (18:0) 3.47 0.68 1.09 (1.02, 1.16) 1.06 (0.99, 1.13) 1.04 (0.98, 1.11) 1.01 (0.90, 1.12) 0.92 (0.83, 1.03)
Sum of butyric (4:0) 
to capric (10:0) 
acids
0.67 0.28 1.00 (0.94, 1.07) 0.87 (0.81, 0.94) 0.91 (0.85, 0.98) 0.86 (0.79, 0.94) 0.93 (0.85, 1.01)
Sum of pentadecylic 
(15:0) and marga-
ric(17:0) acids
0.37 0.11 1.04 (0.97, 1.10) 0.93 (0.87, 0.99) 0.96 (0.89, 1.02) 0.78 (0.69, 0.87) 0.88 (0.79, 0.99)
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0.73, 0.97) and odd-chain SFA (pentadecylic plus margaric 
acids;  HRper SD increase: 0.88; 95% CI 0.79, 0.99). No sig-
nificant associations were observed for intakes of short- and 
medium-chain SFA (butyric through capric), palmitic, pen-
tadecylic and stearic acids.
Intake of SFA from different food sources and risk 
of T2D
A significant inverse association was observed 
between intake of cheese derived SFA and risk of T2D 
 (HRper SD increase: 0.90; 95%I 0.83, 0.98) after multivariable 
adjustment (model 5), but not for milk and milk products 
derived SFA  (HRper SD increase: 1.01; 95% CI 0.93,1.10). 
Higher intake of soft and liquid fats derived SFA was associ-
ated with a higher risk of T2D  (HRper SD increase: 1.08; 95%CI 
1.01, 1.17). No significant associations were observed for 
intake of SFA from other food sources (Table 4).
Substitution of SFA by other macronutrients
Table 5 presents risks of T2D for each additional intake of 
1% of energy from vegetable protein, animal protein, MUFA, 
PUFA or carbohydrates at the expense of equal amounts of 
energy from SFA. After multivariable adjustment (model 
5), we found that substituting SFA with animal protein (HR 
per 1% of energy: 1.12; 95% CI 1.07, 1.17) or carbohydrates (HR 
per 1% of energy: 1.05; 95% CI 1.02, 1.08) was associated with 
a significantly higher risk of developing T2D. Surprisingly, 
we also observed an increased T2D risk when substituting 
SFA with vegetable protein (HR per 1% of energy: 1.15; 95% CI 
1.03, 1.28) or PUFA (HR per 1% of energy: 1.15; 95% CI 1.04, 
1.27). Substituting SFA with carbohydrates differing in GI 
values resulted in differences in T2D risk: substitution with 
high GI carbohydrates associated with a higher risk of T2D 
(HR per 1% of energy: 1.12; 95% CI 1.06, 1.19), whereas substi-
tution with low- or medium GI carbohydrates did not relate 
to T2D risk. No significant association was observed with 
substitution of SFA with MUFA.
Sensitivity analysis
No significant effect modification of family history (P 
values: 0.13–0.99) and energy reporting status (P values: 
0.20–0.99) was found. Moreover, no meaningful effect 
modifications by baseline BMI and sex were observed for 
the relations of SFA and T2D (for all three approaches: indi-
vidual SFA, SFA from food groups, and substitution with 
other macronutrients), but interactions existed between sex 
and substituting SFA with animal protein and PUFA (P val-
ues all < 0.01). Stratification for sex in substitution models 
indicated a significant higher risk of T2D in women when 
substituting SFA with animal protein or PUFA, whereas this 
association was not present in men (Supplemental Table 4). 
Our results did not materially change after excluding the first 
2 years of follow-up  (SFAtotal HR per 1% of energy: 0.97; 95% CI 
0.93, 1.00), or restricting analyses by including only baseline 
healthy participants  (SFAtotal HR per 1% of energy: 1.01; 95% CI 
Table 4  Multivariable HRs with 95% CIs for the associations between intake of SFA from different food sources (en %) and incidence of type 2 
diabetes in 37,421 participants from the EPIC-NL cohort
Obtained from Cox proportional hazards regression models. EPIC-NL, European Prospective Investigation into Cancer and Nutrition-Nether-
lands
a HRs are expressed per SD en%
b Crude model; adjusted for total energy intake
c Adjustment for sex, age and sum of other SFA
d Additional adjustments for education level, energy-adjusted alcohol consumption level, smoking status, physical activity level
e Additional adjustments for energy-adjusted intake of animal protein, vegetable protein, trans fatty acids, vitamin E, dietary fibre and cholesterol
f Additional adjustments for BMI and waist circumference
SFA from: Median 
intake en%/
day
SDa Model  1b Model  2c Model  3d Model  4e Model  5f
Butter 0.67 1.44 0.96 (0.89, 1.03) 0.88 (0.82, 0.95) 0.90 (0.84, 0.97) 0.93 (0.86, 1.01) 0.93 (0.86, 1.01)
Cheese 2.33 1.98 0.93 (0.87, 1.00) 0.89 (0.83, 0.95) 0.94 (0.88, 1.01) 0.86 (0.79, 0.93) 0.90 (0.83, 0.98)
Milk and milk products 2.30 1.47 1.10 (1.03, 1.17) 1.02 (0.95, 1.09) 0.99 (0.92, 1.05) 0.96 (0.89, 1.04) 1.01 (0.93, 1.10)
Meat 2.53 1.47 1.22 (1.15, 1.29) 1.23 (1.17, 1.31) 1.20 (1.13, 1.28) 1.10 (1.02, 1.19) 1.03 (0.95, 1.11)
Cakes and cookies 0.81 0.84 1.02 (0.95, 1.08) 0.88 (0.82, 0.95) 0.89 (0.83, 0.96) 0.94 (0.87, 1.01) 0.97 (0.90, 1.05)
Snacks 0.30 0.40 0.71 (0.65, 0.77) 1.00 (0.92, 1.09) 1.01 (0.93, 1.10) 0.96 (0.87, 1.06) 0.90 (0.81, 1.00)
Hard, solid fats 1.02 1.27 1.13 (1.07, 1.20) 1.05 (0.99, 1.12) 0.98 (0.92, 1.05) 0.96 (0.89, 1.04) 0.98 (0.91, 1.06)
Soft, liquid fats 0.59 0.51 1.16 (1.09, 1.23) 1.11 (1.04, 1.18) 1.12 (1.06, 1.19) 1.08 (0.99, 1.16) 1.08 (1.01, 1.17)
Others 2.57 1.08 0.79 (0.73, 0.85) 0.98 (0.90, 1.05) 1.00 (0.92, 1.08) 0.95 (0.86, 1.06) 0.96 (0.87, 1.06)
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0.94, 1.08). Associations between non-SFA fatty acids from 
specific food sources and T2D risk were fairly similar to 
associations between SFA from that food sources and T2D 
risk (Supplemental Table 5).
Discussion
In this large prospective cohort study of 37,421 participants, 
we found that the association between dietary SFA and risk 
of T2D is partly depending on the types and food sources of 
SFA. While no association was found for dietary total SFA, 
inverse associations with T2D were observed for dietary lau-
ric acid, myristic acid, margaric acid and sum of odd-chains 
SFA, and cheese derived SFA. We also found a modestly 
higher T2D risk for soft and liquid fats derived SFA, and 
for substituting total SFA with proteins, carbohydrates or 
PUFA.
Strengths of this study include the prospective design 
which minimized possible recall bias, and a high follow-up 
retention rate of 97.6% which reduced bias caused by loss 
to follow-up. In addition, verification of ascertained cases 
of T2D diminished the presence of false-positive cases and 
increased validity of outcome measurement, although mis-
classification could still remain due to no verification of 
self-reported non-diabetic participants [28]. Several limita-
tions need to be addressed. First of all, the information of 
dietary intake, including SFA intake, was measured with 
one FFQ at baseline and without repeated assessments. The 
FFQ relies on self-report and is prone to imprecision and 
reporting bias. Additionally, we were not able to take into 
account changes in dietary intake during follow-up, which 
might have diluted the observed associations. Moreover, 
the intake of SFA was on average high, with little variation 
between individuals. This may have limited us in detecting 
associations of SFA with T2D. Also, the high correlations 
of intake of SFA from specific food sources with the total 
fatty acids from that food sources and the food source itself 
suggest that we were unable to distinguishing food-derived 
SFAs from its food source in relation to T2D risk. This was 
also confirmed in the additional analyses, where we mod-
elled non-SFA fatty acids from different food source and 
risk of T2D. Associations with T2D risk for non-SFA fatty 
acids from specific food sources were all similar to those 
for SFAs from that food sources. Furthermore, although all 
possible available confounders were corrected for, we can-
not exclude the possibility of influences from residual con-
founding, such as cholesterol-lowering medication during 
follow-up. It could be hypothesized that participants with 
higher intake of SFA will have a higher cholesterol levels 
and are more eligible to take cholesterol-lowering medica-
tion [29]. In the Doetinchem cohort, a sub-cohort of EPIC-
NL which was examined every 5 years, a noticeable increase 
of cholesterol-lowering medication usage was observed over 
time [30]. Evidence from a collaborative meta-analysis of 
clinical trials showed that cholesterol-lowering medication 
is associated with higher risk of T2D [31]. This may have 
partly affected our findings towards neutral. Finally, due to 
the many analyses that were performed in this study, we 
cannot exclude chance findings.
Table 5  Multivariable HRs with 95% CIs for the association between 
the consumption of 1% of energy from different macronutrients at the 
expense of 1% of energy from total SFA while keeping total energy 
intake constant and incident type 2 diabetes in 37,495 participants 
from the EPIC-NL cohort
Obtained from Cox proportional hazards regression models. EPIC-NL, European Prospective Investigation into Cancer and Nutrition-Nether-
lands
a Crude substitution model; adjustment for total energy intake
b Adjustment for sex and age
c Additional adjustments for education level, energy-adjusted alcohol consumption level, smoking status, physical activity level
d Additional adjustments for energy-adjusted intake of trans fatty acids, vitamin E, dietary fibre and cholesterol
e Additional adjustments for BMI and waist circumference
f Number of cases for low GI: 322; medium GI: 290; and high GI: 281
Model  1a Model  2b Model  3c Model  4d Model  5e
Vegetable protein 1.02 (0.94, 1.10) 1.09 (1.00, 1.18) 1.12 (1.04, 1.22) 1.20 (1.07, 1.33) 1.15 (1.03, 1.28)
Animal protein 1.20 (1.16, 1.24) 1.21 (1.17, 1.25) 1.22 (1.17, 1.28) 1.21 (1.16, 1.27) 1.12 (1.07, 1.17)
MUFA 1.03 (0.98, 1.08) 1.09 (1.03, 1.14) 1.11 (1.05, 1.18) 1.09 (1.03, 1.16) 1.04 (0.98, 1.11)
PUFA 1.19 (1.14, 1.25) 1.20 (1.15, 1.25) 1.21 (1.15, 1.27) 1.20 (1.08, 1.33) 1.15 (1.04, 1.27)
Carbohydrates 1.03 (1.01, 1.05) 1.05 (1.03, 1.07) 1.06 (1.03, 1.09) 1.07 (1.04, 1.10) 1.05 (1.02, 1.08)
Carbohydrates with a low  GIf 1.04 (1.01, 1.07) 1.04 (1.01, 1.07) 1.04 (1.00, 1.09) 1.03 (0.98, 1.08) 1.01 (0.97, 1.06)
Carbohydrates with a medium  GIf 1.00 (0.97, 1.04) 1.02 (0.98, 1.06) 1.01 (0.96, 1.07) 1.02 (0.97, 1.08) 1.00 (0.95, 1.06)
Carbohydrates with a high  GIf 1.05 (1.01, 1.09) 1.11 (1.06, 1.15) 1.13 (1.08, 1.20) 1.15 (1.09, 1.22) 1.12 (1.06, 1.19)
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In line with a recent meta-analysis of eight prospective 
studies [6], we observed no association between dietary 
intake of total SFA and T2D risk. This lack of association 
no longer held when the carbon chain length of individ-
ual SFA was taken into account. Although three previous 
studies have examined the association of dietary individual 
SFA with T2D risk, only a selection of individual SFA was 
included [7, 9, 10]. We evaluated a more complete profile of 
individual SFA. We observed that dietary lauric and myris-
tic acids were inversely associated with T2D risk, whereas 
dietary palmitic and stearic acids were not related to T2D 
risk. These findings are in line with the Malmö Diet and 
Cancer (MDC) cohort study [7]. In the MDC cohort study, 
dietary intake of SFA with 4–10 carbons was inversely asso-
ciated with T2D risk, whereas the present study observed 
no association for these SFA with T2D after adjustment for 
BMI and waist circumference. In the MDC cohort study, the 
association after adjustment for BMI was also attenuated, 
but remained statistically significant. Differences in find-
ings may be due to a smaller variation of intake of SFA with 
4–10 carbons in our study population (IQR 0.5–0.8 energy 
percentage) compared to the MDC study (IQR 0.7–2.6 
energy percentage). Additionally, whether overweight is 
a confounder or mediator in the association between SFA 
and T2D still remains unclear, and we cannot exclude pos-
sible over-adjustment by overweight in our study. This also 
applies to the association of pentadecylic acid with T2D 
which attenuated and became non-significant after adjust-
ment for BMI and waist circumference. A case-cohort study 
of 3737 men and women also observed no association for 
dietary palmitic, stearic, and pentadecylic acids, which fur-
ther supports our findings [10]. Any comparison between 
our study and the third study, a case-cohort study among 
participants of the EPIC-Norfolk study, is limited due to 
differences in adjustments for dietary factors such as trans 
fatty acids and cholesterol [9]. None of these three previous 
studies have investigated dietary intake of margaric acid and 
odd-chain SFA (pentadecylic plus margaric acids), which 
we found were inversely associated with T2D risk. These 
findings are consistent with the existing evidence from the 
EPIC-InterAct study, where plasma phospholipid odd-chain 
SFA, which are reasonable biomarkers for dietary intake of 
odd-chain SFAs, were inversely related to T2D risk in the 
InterAct study that included participants from our cohort [8].
The associations we observed for individual SFA cor-
respond to our findings for SFA derived from different food 
sources. To our knowledge, this is the first observational 
study that investigated SFA from different food sources in 
relation to incident T2D. We observed that dietary SFA 
derived from cheese was inversely related to T2D risk. This 
finding is supported by previous studies that found intake of 
cheese to be associated with lower T2D risk [7, 32], although 
not consistently [13]. Given the high correlations of cheese 
and cheese-derived SFA (r = 0.98, Supplemental Table 3), 
it is difficult to conclude whether the observed inverse asso-
ciation of cheese derived SFA is due to (particular) SFA, 
cheese as a whole product, or other constituents present in 
cheese such as calcium [33]. Moreover, we did not observe 
any association with SFA derived from milk and milk prod-
ucts, despite that SFA types present in milk are similar to 
cheese. This could be due to the lower SFA content in milk 
and milk products (and lower variation in intake compared 
to cheese SFA), or due to differences in food matrices and 
fermentation of cheese and milk (products) [34]. Additional 
adjustments for two cheese-constituents, calcium and vita-
min D, did not alter the associations of SFA from cheese 
with T2D, but this does not fully exclude the possibility that 
we are looking at more than SFA in cheese. Also, we did not 
observe any association with SFA derived from butter. These 
findings are consistent with the Netherlands Epidemiology 
of Obesity (NEO) study, which suggests that SFA from but-
ter or milk is not associated with glucose–insulin metab-
olism [11]. Additionally, this is in agreement with recent 
meta-analyses that reported no associations between butter, 
milk and milk products and T2D [13, 35]. Our observed 
harmful association for meat derived SFA  (HRper SD increase: 
1.10; 95% CI 1.02, 1.19) is also in line with existing evi-
dence [11, 36]. When we additionally adjusted for BMI and 
waist circumference, however, the observed association 
attenuated and became non-significant  (HRper SD increase: 1.03; 
95% CI 0.95, 1.11).
As far as we know, no previous studies have investigated 
substitutions of SFA with protein, carbohydrate nor MUFA 
in relation to T2D risk. We found substituting SFA with 
carbohydrate, animal protein, vegetable protein or PUFA 
was associated with higher T2D risk, but not with MUFA. 
Previous studies suggest that animal protein is related to 
a higher T2D risk [37–39], which supported our observa-
tions. Several cohort studies linked total carbohydrates to a 
higher risk of T2D [40–42], while others suggested a non-
significant inverse association [43–45]. Nevertheless, our 
analysis suggests that either animal protein or total carbo-
hydrates is worse than SFA with respect to T2D risk. Per-
haps, this is because a large part of SFA consumed by our 
study population was derived from dairy products, and those 
seem to be beneficial with respect to T2D risk [13]. This 
might also have contributed to the finding that substitut-
ing vegetable protein for SFA related to higher T2D risk. 
Moreover, the small range of intake in vegetable protein may 
have contributed to this finding. Yet, it remains unclear why 
substituting SFA with PUFA was related to a higher T2D 
risk in our study. As suggested by previous studies [14, 15], 
such substitution was expected to be inversely associated 
with T2D risk. A possible explanation for this unexpected 
finding is the food sources of SFA and PUFA in this study 
population. Margarines, as a food source of PUFA, also 
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contained trans fatty acids at the beginning of the study. 
During the mid-1990s, there was a notable reduction of 
trans fatty acids content in margarines. This may have led 
to residual confounding by underestimated trans fatty acids 
intake, consequently affecting the observed association of 
substituting SFA with PUFA. This may also explain why we 
found higher T2D risk with SFA from soft and liquid fats. 
Furthermore, compared to the Nurses’ Health Study (80% 
central range 2.9–6.2 energy percentage), the intake range 
of PUFA is relatively small in our study (80% central range 
4.9–7.6 energy percentage). As we only found adverse asso-
ciation for substituting SFA with animal protein or PUFA in 
women in the gender-stratified analysis, the result could be 
largely driven by the large proportion of women in our study. 
Altogether, the increased T2D risks when substituting SFA 
by proteins, carbohydrates, and especially PUFA, needs to 
be interpreted with caution.
In conclusion, our findings emphasize the importance of 
distinguishing between the types and food sources of SFA 
in relation to T2D risk. Our study suggests that individual 
SFA that exist to a large extent in cheese, and SFA derived 
from cheese, relate to a lower T2D risk. Regarding substitu-
tion of SFA with other macronutrients, we cannot exclude 
the possibility that our results reflect inverse associations of 
dairy-derived fatty acids with T2D and/or residual confound-
ing by trans fatty acid intake. Further investigation is still 
warranted, especially in populations with other dietary pat-
terns contributing to SFA intake, and with more variation in 
intake of PUFA, to draw further conclusions of the relations 
of SFA with T2D risk.
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